Skip to Main Content
Table 1—

Patient characteristics

Number of patients 22 
Age (years) 63.7 ± 1.8 (41–76)* 
Sex 13 males, 9 females 
BMI (kg/m232.8 ± 1.4 
Type of diabetes 2 type 1, 20 type 2 
Duration of diabetes (years) 9.1 ± 1.5 
Duration of neuropathy (years) 3.0 ± 0.5 
Duration of neuropathic pain (years) 2.5 ± 0.4 
Treatment order 10 ISDN, 12 placebo 
HbA1c (%)  
 At study entry 7.8 ± 0.3 
 At study completion 8.1 ± 0.4 
Number of patients 22 
Age (years) 63.7 ± 1.8 (41–76)* 
Sex 13 males, 9 females 
BMI (kg/m232.8 ± 1.4 
Type of diabetes 2 type 1, 20 type 2 
Duration of diabetes (years) 9.1 ± 1.5 
Duration of neuropathy (years) 3.0 ± 0.5 
Duration of neuropathic pain (years) 2.5 ± 0.4 
Treatment order 10 ISDN, 12 placebo 
HbA1c (%)  
 At study entry 7.8 ± 0.3 
 At study completion 8.1 ± 0.4 
*

Data are n or means ± SE. Age range;

HbA1c reference range 4.9–6.3%.

Close Modal

or Create an Account

Close Modal
Close Modal